29 results on '"Chilkulwar A"'
Search Results
2. Microbiome and Allogeneic Hematopoietic Stem Cell Transplantation
3. Contributors
4. COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort
5. Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy
6. Herpes zoster in chronic lymphocytic leukemia: Effect of vaccination and treatment.
7. Industry Payment to Vascular Neurologists
8. Donor Sex, Age, and Body Mass Index on Bone Marrow Harvest Collection Quality Outcomes
9. Multiple Myeloma :Trends in Consulting Fees and Drug Utilization
10. Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes
11. Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome
12. Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature
13. Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
14. Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors.
15. Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia
16. Hemophagocytic Lymphohistiocytosis Secondary to Bone Marrow Only B-Cell Lymphoma: A Very Rare Entity With an Even Rarer Presentation
17. Toxic Hemolysis in a Young Healthy Female
18. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)
19. Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma
20. Maintenance therapy in multiple myeloma
21. High serum free light chain concentration (>1000mg/dl) at the time of relapse to predict poor prognosis in multiple myeloma.
22. No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study
23. Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL
24. A Retrospective, Single Institution Study Comparing 5-Fluorouracil, Hydroxyurea, and Twice-Daily Radiation Therapy (FHX) to High-Dose Cisplatin + Radiation Therapy (CRT) in Advanced T Stage Head-and-Neck Squamous Cell Carcinoma (ATSHNSCC)
25. Prevalence of Colorectal Neoplasms in African Americans in the Age Group of 40-44 Years
26. Mo1182 Colorectal Neoplasm Prevalence in African American and Hispanic Patients in Different Age Groups
27. Dosimetric evaluation of an indigenously developed 10 MeV industrial electron beam irradiator
28. Dosimetry during mango irradiation using Gafchromic HD-810 film
29. A dose verification method for high-dose-rate brachytherapy treatment plans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.